Immunotech Laboratories (IMMB) Financial Statements

11 Followers

Immunotech Laboratories Financial Overview

Immunotech Laboratories's market cap is currently $114.99K. The company's EPS TTM is $; its P/E ratio is -0.22; Immunotech Laboratories is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 16
Income Statement
Total Revenue	$ 0.00
Gross Profit	$ -305.55K
Operating Income	$ -470.36K
EBITDA	$ -454.01K
Net Income	$ -493.03K
Balance Sheet
Cash & Short-Term Investments	$ 14.29K
Total Assets	$ 10.53M
Total Debt	$ 2.42M
Net Debt	$ 2.40M
Total Liabilities	$ 5.73M
Stockholders' Equity	$ 4.80M
Cash Flow
Free Cash Flow	$ -31.16K
Operating Cash Flow	$ -31.16K
Investing Cash Flow	$ 16.35K
Financing Cash Flow	$ 24.05K

Currency in USD

Immunotech Laboratories Earnings and Revenue History

Income Statement >

Immunotech Laboratories Debt to Assets

Balance Sheet >

Immunotech Laboratories Cash Flow

Cash Flow >

Immunotech Laboratories Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >